Financial Year |
March 31 2023 |
Monetary Funds |
848,547,437.45 |
Held-for-trading Financial Assets |
150,565,616.44 |
Notes Receivable |
5,614,500.00 |
Accounts Receivable |
437,584,945.67 |
Advances to Suppliers |
744,630.06 |
Other Receivables |
7,978,367.87 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
779,300,690.28 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
4,276,471.34 |
Total Current Assets |
2,401,662,730.78 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
967,153,698.68 |
Under-construction Projects |
6,753,998.19 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
59,973,247.84 |
R&D expenses |
-- |
Goodwill |
6,981,777.93 |
Long-Term Deferred and Prepaid Expenses |
4,087,657.19 |
Deferred Income Tax Assets |
26,874,424.89 |
Other Non-Current Assets |
13,844,169.91 |
Sub-Total of Non-Current Assets |
1,085,668,974.63 |
Total Assets |
3,487,331,705.41 |
Short-Term Loans |
92,075,961.11 |
Trading Financial liabilities |
-- |
Notes Payable |
533,599,928.41 |
Accounts Payable |
511,987,777.92 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
45,343,934.75 |
Taxes Payable |
5,238,598.53 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
11,574,281.34 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
20,024.75 |
Other Current Liabilities |
4,604,797.63 |
Sub-Total of Current Liabilities |
1,232,298,521.11 |
Long-term Loans |
4,986,162.75 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
30,540,079.42 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
50,878,655.95 |
Total Liabilities |
1,283,177,177.06 |
Paid-In Capital(Or Share Stock) |
419,160,301.00 |
Capital Surplus |
1,385,627,088.30 |
Surplus Reserve |
77,556,476.56 |
LESS:Treasury Stock |
10,128,600.00 |
Undistributed Profits |
275,004,058.61 |
Minority Stockholder's Interest |
56,935,203.88 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,147,219,324.47 |
Owner's Equity(Stockholder's Equity) |
2,204,154,528.35 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,487,331,705.41 |